Cargando…
Anti CD-6 Monoclonal Antibodies in the Management of Generalised Pustular Psoriasis
Generalised pustular psoriasis (GPP) is an uncommon, severe, life-threatening variant of psoriasis requiring careful therapeutic approach. Conventional treatment modalities have unsatisfactory outcomes, poor side effect profiles and toxicities that have led to an emerging use of biological therapies...
Autores principales: | Kura, Mahendra M., Sodhi, Anmol, Sajgane, Avinash, Karande, Ashish |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971756/ https://www.ncbi.nlm.nih.gov/pubmed/36865872 http://dx.doi.org/10.4103/ijd.ijd_180_21 |
Ejemplares similares
-
Prolonged Remission of Psoriasis with Azathioprine Pulse Therapy
por: Gupta, Ramji
Publicado: (2015) -
Acrodermatitis Continua of Hallopeau Evolving into Generalised Pustular Psoriasis
por: Ranugha, Poovanur SS, et al.
Publicado: (2013) -
Role of Interleukin 36 in Generalised Pustular Psoriasis and Beyond
por: Sugiura, Kazumitsu
Publicado: (2022) -
EVALUATION OF TOPICAL 0.1% TAZAROTENE CREAM IN THE TREATMENT OF PALMOPLANTAR PSORIASIS: AN OBSERVER-BLINDED RANDOMIZED CONTROLLED STUDY
por: Mehta, Bijal H, et al.
Publicado: (2011) -
COMPARATIVE THERAPEUTIC EVALUATION OF DIFFERENT TOPICALS AND NARROW BAND ULTRAVIOLET B THERAPY COMBINED WITH SYSTEMIC METHOTREXATE IN THE TREATMENT OF PALMOPLANTAR PSORIASIS
por: Gupta, Sunil K, et al.
Publicado: (2011)